Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
11 studies found for:    ANGIOEDEMA, HEREDITARY, TYPE I
Show Display Options
Rank Status Study
1 Completed Kinetics, Efficacy and Safety of C1-Esteraseremmer-N
Conditions: Hereditary Angioedema Type I;   Angioneurotic Edema
Intervention: Drug: C1 inhibitor concentrate
2 Recruiting Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Intervention: Drug: Ecallantide subcutaneous dosing
3 Recruiting A Study to Evaluate the Clinical Efficacy and Safety of Subcutaneously Administered C1-esterase Inhibitor in the Prevention of Hereditary Angioedema
Condition: Hereditary Angioedema Types I and II
Interventions: Biological: Low-volume C1-esterase inhibitor;   Biological: Higher-volume C1-esterase inhibitor;   Biological: Low-volume placebo;   Biological: Higher-volume placebo
4 Completed A Study to Evaluate the Clinical Pharmacology and Safety of C1-esterase Inhibitor Administered by the Subcutaneous Route
Condition: Hereditary Angioedema Types I and II
Interventions: Biological: C1-esterase inhibitor - single intravenous dose;   Biological: C1-esterase inhibitor - subcutaneous low dose;   Biological: C1-esterase inhibitor - subcutaneous medium dose;   Biological: C1-esterase inhibitor - subcutaneous high dose
5 Completed Postmarketing Immunogenicity Study in HAE Subjects Treated With Berinert
Condition: Hereditary Angioedema Types I and II
Intervention: Biological: Berinert, lyophilisate for IV application containing 500 units (U) C1-INH to be reconstituted with 10 mL water for injection
6 Completed A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor
Condition: Hereditary Angioedema Types I and II
Interventions: Biological: Berinert;   Biological: CSL830
7 Completed A Study to Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic Asthma
Condition: Allergic Asthma
Intervention: Drug: HAE1 (PRO98498)
8 Completed C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema
Condition: Angioedema
Intervention: Drug: C1 inhibitor concentrate (C1-esteraseremmer-N)
9 Completed C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema
Condition: Angioedema
Intervention: Drug: C1 inhibitor concentrate (C1-esteraseremmer-N)
10 Completed
Has Results
A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)
Condition: Hereditary Angioedema
Interventions: Drug: Icatibant;   Drug: Placebo
11 Completed
Has Results
EASSI - Evaluation of the Safety of Self-Administration With Icatibant
Condition: Hereditary Angioedema
Intervention: Drug: Icatibant

Indicates status has not been verified in more than two years